Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 9090

BillFederalHouseIn Committee
Advancing Menopause Care and Mid-Life Women’s Health Act
About This Bill
Committee
Latest Action · June 2, 2026
Referred to the House Committee on Energy and Commerce.
Congress
119th (2025–2027)
Introduced
June 2, 2026
Cosponsors (7)
7D 0R
View PDF ↗

Summary

Highlight any text to annotate
H.R. 9090, the Advancing Menopause Care and Mid-Life Women's Health Act, directs the National Institutes of Health and the Department of Health and Human Services to expand research on menopause and mid-life women's health, including studies on symptoms, treatments, and health disparities affecting women during perimenopause, menopause, and postmenopause. The bill authorizes $25 million annually through 2031 to support biomedical research, clinical studies, and the establishment of Centers of Excellence that will develop and distribute evidence-based treatment resources to healthcare providers and patients, with priority given to centers serving rural and medically underserved areas. The legislation also requires research on how menopausal symptoms affect women in the workplace and mandates coordination across federal agencies including Veterans Affairs and the Defense Department to ensure integrated efforts and avoid duplicating programs. This comprehensive approach aims to improve both the care and understanding of menopause-related health issues affecting millions of American women.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.